The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today ...
Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...
Unichem Pharmaceuticals has issued a voluntary recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg after the incorrect label was placed on the wrong product. FDA announced on Aug. 27, 2025 that ...
PHILADELPHIA - (Business Wire) Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...
Mumbai: Lupin Limited announced the launch of Sevelamer Hydrochloride Tablets, 800 mg, having received an approval from the United States Food and Drug Administration (FDA). The product will be ...
Hydroxyzine Hydrochloride Tablets had U.S. sales of approximately $55 million for the 12 months ending March 31, 2010, according to IMS Health. Currently, Mylan has 138 ANDAs pending FDA approval ...
Get all latest & breaking news on Donepezil Hydrochloride Tablets. Watch videos, top stories and articles on Donepezil ...
MUMBAI, India and NAPLES, Fla., April 8, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results